CIA
ANGO icon

Concurrent Investment Advisors’s AngioDynamics ANGO Stock Holding History

Concurrent Investment Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.6K Hold
1,200
– – ﹤0.01% 1915
2025
Q4 		$15.4K Buy
1,200
+1,000
+500% +$12.3K ﹤0.01% 1762
2025
Q3 		$2.23K Buy
+200
New +$1.93K ﹤0.01% 1495
2025
Q2 		– Sell
-1,000
Closed -$9.39K – 1411
2025
Q1 		$9.39K Buy
+1,000
New +$10.5K ﹤0.01% 1229

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Concurrent Investment Advisors's ANGO Position: Q1 2026 in Review

Concurrent Investment Advisors increased its AngioDynamics (ANGO) stake by 0.07% in Q1 2026, buying an estimated $163 and bringing the position to 21,677 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #1617.

Concurrent Investment Advisors first reported a position in ANGO in Q4 2023 and has held it in 10 quarters since. The position peaked at $330K in Q3 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Concurrent Investment Advisors held 21,677 shares of AngioDynamics worth $246K as of Q1 2026.
  • Concurrent Investment Advisors bought 15 AngioDynamics shares in Q1 2026, an estimated $163.
  • AngioDynamics made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q1 2026, its #1617 holding.
  • Concurrent Investment Advisors first reported a position in AngioDynamics in Q4 2023 and has held it in 10 quarters since.
  • Concurrent Investment Advisors's AngioDynamics position peaked at $330K in Q3 2025.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.